Announcements Trials
Browse Landscape

Status

Completed 6Unknown 1

Sponsor Class

OTHER 31INDUSTRY 7NETWORK 4OTHER_GOV 1

Study Type

Interventional 932Observational 7Expanded_access 2

Sponsor

Cancer Type

Thoracic 3Gynecologic 3Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Dysplasia 2Ovarian Neoplasms 1Breast Neoplasms 1

Interventions

Blood Specimen Collection 31Sorafenib 29Nivolumab 29Bevacizumab 26Data Collection 24Observation 23palbociclib 22Sunitinib 22radium Ra 223 dichloride 20enzalutamide 18Rituximab 18Ipilimumab 16regorafenib 15Drug Therapy 15Trastuzumab 14Docetaxel 14ribociclib 12exemestane 12atezolizumab 12Standard of Care 12darolutamide 11apalutamide 11Leuprolide 11Capecitabine 11Afatinib 11Bortezomib 10Anastrozole 10trastuzumab deruxtecan 9pembrolizumab 9avelumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Paclitaxel × Clear all
NCT07141563 2026-01-07

A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC

Bristol-Myers Squibb

Completed
70 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05834348 2025-03-30

DELINOR

Pfizer

Completed
5,279 enrolled 10 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02613208 2020-02-17

Argo

Hoffmann-La Roche

Completed
111 enrolled 14 charts
Breast

Breast Neoplasms

NCT02393898 2019-07-24

BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and Older

Hoffmann-La Roche

Completed
76 enrolled
Gynecologic

Ovarian Neoplasms

NCT03195569 2017-06-22

To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer

Qilu Pharmaceutical Co., Ltd.

Unknown
15 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01345279 2017-05-30

Indirect Comparison Topotecan Cervical Carcinoma

GlaxoSmithKline

Completed
1 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT01160185 2010-07-12

Meta-analysis of Efficacy of Topotecan

GlaxoSmithKline

Completed
1 enrolled
Gynecologic

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡